Nikolai A Nikitin
Overview
Explore the profile of Nikolai A Nikitin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
259
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khudainazarova N, Granovskiy D, Kondakova O, Ryabchevskaya E, Kovalenko A, Evtushenko E, et al.
Int J Mol Sci
. 2024 Nov;
25(22).
PMID: 39596049
This review addresses the ongoing global challenge posed by emerging and evolving viral diseases, underscoring the need for innovative vaccine development strategies. It focuses on the modern approaches to creating...
2.
Vasyagin E, Zykova A, Mardanova E, Nikitin N, Shuklina M, Ozhereleva O, et al.
Vaccines (Basel)
. 2024 Sep;
12(9).
PMID: 39340063
Efficient control of influenza A infection can potentially be achieved through the development of broad-spectrum recombinant vaccines based on conserved antigens. The extracellular domain of the transmembrane protein M2 of...
3.
Sokol O, Nikitin N, Evtushenko E, Karpova O, Matveeva I, Gryn S, et al.
Biochemistry (Mosc)
. 2024 Apr;
89(3):574-582.
PMID: 38648774
Rabies is a zoonotic disease with high lethality. Most human deaths are associated with the bites received from dogs and cats. Vaccination is the most effective method of preventing rabies...
4.
Granovskiy D, Khudainazarova N, Evtushenko E, Ryabchevskaya E, Kondakova O, Arkhipenko M, et al.
Viruses
. 2024 Mar;
16(3).
PMID: 38543803
Rotavirus infection is a leading cause of severe dehydrating gastroenteritis in children under 5 years of age. Although rotavirus-associated mortality has decreased considerably because of the introduction of the worldwide...
5.
Ksenofontov A, Petoukhov M, Matveev V, Fedorova N, Semenyuk P, Arutyunyan A, et al.
Biochemistry (Mosc)
. 2023 Apr;
88(1):119-130.
PMID: 37068873
The amino acid sequences of the coat proteins (CPs) of the potexviruses potato virus X (PVX) and alternanthera mosaic virus (AltMV) share ~40% identity. The N-terminal domains of these proteins...
6.
Kozlovskaya L, Osolodkin D, Tuchynskaya K, Shevtsova A, Okhezin E, Palyulin V, et al.
Arch Virol
. 2023 Mar;
168(3):100.
PMID: 36871232
Introduction of point mutations is one of the forces enabling arboviruses to rapidly adapt in a changing environment. The influence of these mutations on the properties of the virus is...
7.
New formulation of a recombinant anthrax vaccine stabilised with structurally modified plant viruses
Granovskiy D, Ryabchevskaya E, Evtushenko E, Kondakova O, Arkhipenko M, Kravchenko T, et al.
Front Microbiol
. 2022 Sep;
13:1003969.
PMID: 36160184
Anthrax is a disease caused by . The most promising approach to the development of anthrax vaccine is use of the anthrax protective antigen (PA). At the same time, recombinant...
8.
Kondakova O, Evtushenko E, Baranov O, Nikitin N, Karpova O
Biochemistry (Mosc)
. 2022 Jul;
87(6):548-558.
PMID: 35790410
Structurally modified virus particles can be obtained from the rod-shaped or filamentous virions of plant viruses and bacteriophages by thermal or chemical treatment. They have recently attracted attention of the...
9.
Ryabchevskaya E, Granovskiy D, Evtushenko E, Ivanov P, Kondakova O, Nikitin N, et al.
Pharmaceutics
. 2022 Apr;
14(4).
PMID: 35456639
Anthrax is a disease caused by that affects mammals, including humans. Recombinant protective antigen (rPA) is the most common basis for modern anthrax vaccine candidates. However, this protein is characterised...
10.
Kovalenko A, Ryabchevskaya E, Evtushenko E, Manukhova T, Kondakova O, Ivanov P, et al.
Front Microbiol
. 2022 Mar;
13:845316.
PMID: 35295298
A recombinant vaccine candidate has been developed based on the major coronaviruses' antigen (S protein) fragments and a novel adjuvant-spherical particles (SPs) formed during tobacco mosaic virus thermal remodeling. The...